Unknown

Dataset Information

0

Single-cell lineage analysis reveals genetic and epigenetic interplay in glioblastoma drug resistance.


ABSTRACT: BACKGROUND:Tumors can evolve and adapt to therapeutic pressure by acquiring genetic and epigenetic alterations that may be transient or stable. A precise understanding of how such events contribute to intratumoral heterogeneity, dynamic subpopulations, and overall tumor fitness will require experimental approaches to prospectively label, track, and characterize resistant or otherwise adaptive populations at the single-cell level. In glioblastoma, poor efficacy of receptor tyrosine kinase (RTK) therapies has been alternatively ascribed to genetic heterogeneity or to epigenetic transitions that circumvent signaling blockade. RESULTS:We combine cell lineage barcoding and single-cell transcriptomics to trace the emergence of drug resistance in stem-like glioblastoma cells treated with RTK inhibitors. Whereas a broad variety of barcoded lineages adopt a Notch-dependent persister phenotype that sustains them through early drug exposure, rare subclones acquire genetic changes that enable their rapid outgrowth over time. Single-cell analyses reveal that these genetic subclones gain copy number amplifications of the insulin receptor substrate-1 and substrate-2 (IRS1 or IRS2) loci, which activate insulin and AKT signaling programs. Persister-like cells and genomic amplifications of IRS2 and other loci are evident in primary glioblastomas and may underlie the inefficacy of targeted therapies in this disease. CONCLUSIONS:A method for combined lineage tracing and scRNA-seq reveals the interplay between complementary genetic and epigenetic mechanisms of resistance in a heterogeneous glioblastoma tumor model.

SUBMITTER: Eyler CE 

PROVIDER: S-EPMC7364565 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Single-cell lineage analysis reveals genetic and epigenetic interplay in glioblastoma drug resistance.

Eyler Christine E CE   Matsunaga Hironori H   Hovestadt Volker V   Vantine Samantha J SJ   van Galen Peter P   Bernstein Bradley E BE  

Genome biology 20200715 1


<h4>Background</h4>Tumors can evolve and adapt to therapeutic pressure by acquiring genetic and epigenetic alterations that may be transient or stable. A precise understanding of how such events contribute to intratumoral heterogeneity, dynamic subpopulations, and overall tumor fitness will require experimental approaches to prospectively label, track, and characterize resistant or otherwise adaptive populations at the single-cell level. In glioblastoma, poor efficacy of receptor tyrosine kinase  ...[more]

Similar Datasets

2020-06-18 | GSE142119 | GEO
| PRJNA595940 | ENA
| S-EPMC10236634 | biostudies-literature
| S-EPMC10215375 | biostudies-literature
| S-EPMC4783472 | biostudies-literature
| S-EPMC7646252 | biostudies-literature
| S-EPMC10362028 | biostudies-literature
| S-EPMC3890604 | biostudies-literature
| S-EPMC8809621 | biostudies-literature
2006-01-27 | GSE2221 | GEO